ACTRN12619000561189招募中未知
Hereditary sensory neuropathy type 1 (HSN1) treatment trial to evaluate the effect of L-serine on peripheral nerve function.
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 16 Years 至 o limit（—）
- 性别
- All
入选标准
- •Participants tested positive to SPTLC1 mutations.
- •-Participants showing signs and symptoms of HSN1.
- •-Participants able to visit the clinic in Sydney, Australia (geographically close proximity).
- •-Ambulant subjects.
- •-Participants only taking part in 1 clinical trial at a time.
- •-Participants that are able to provide acceptable/accurate reproducible sensory level measurements.
排除标准
- •-Participants whom have the presence of other forms of neuropathy e.g.-diabetes.
- •-Participants already taking L-serine.
- •-Participants highly dependent on medical care.
- •-Participants with severe nerve degeneration.
- •-Existing alcohol or drug abusers.
- •-Pregnant women.
研究者
相似试验
已完成
1 期
L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1Hereditary Sensory and Autonomic Neuropathy Type INCT01733407Massachusetts General Hospital18
已完成
1 期
A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy SubjectsNetherton SyndromeNCT05583669Daiichi Sankyo24
已完成
1 期
A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy SubjectsNetherton SyndromeNCT05388903Daiichi Sankyo64
进行中（未招募）
不适用
Traitement des syndromes d'hypersensibilité médicamenteuse par Immunoglobuline polyvalente IV (Tégéline ) - DRESS 2EUCTR2006-005748-10-FRCHU - Hôpitaux de Rouen
已完成
早期 1 期
Treatment of HSV-1 (herpes simplex virus type 1) skin florescence of skin types I-III with the diode laser compared to standard treatment with the antiviral drug aciclovirB00.1Herpesviral vesicular dermatitisDRKS00028059Charité-Universitätsmedizin Berlin, Dermatologie30